Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Financial News

Quan doubles down with new $250M fund

September 5, 2019 10:26 PM UTC

With the close of a second fund bringing its managed capital to around $400 million, Quan Capital plans to stick to its strategy of investing in innovative therapeutics, according to Managing Director Marietta Wu.

Wu told BioCentury the firm closed Quan Fund II at $250 million with backing from LPs that come from “most of the major categories of institutional investors” and plans to invest in both early and late stage companies...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article

BCIQ Company Profiles

Quan Capital